The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea

Contraception
I MilsomB Andersch

Abstract

The influence of different oral contraceptives (OC) on the prevalence and severity of dysmenorrhea was investigated longitudinally (from age 19 to 24 years) in a representative sample of young women from an urban Swedish population. The women were grouped according to the type of OC used at the time of assessment: monophasic OC with low gestagen activity; progestogen-dominated monophasic OC; triphasic OC; neither OC nor an intrauterine device (IUD). At the age of 19 years, the severity of dysmenorrhea was lower in users of monophasic OCs with low gestagen activity (p less than 0.05) and users of progestogen-dominated monophasic OCs (p less than 0.001) compared to women who used neither OC nor an IUD. At 24 years of age, the severity of dysmenorrhea was lower in users of monophasic OCs with low gestagen activity (p less than 0.001), users of progestogen-dominated monophasic OCs (p less than 0.001) and users of triphasic OCs (p less than 0.001), compared to women who used neither OC nor an IUD. The severity of dysmenorrhea in women who did not use an OC or IUD when 19 years old was reduced in the same women who used OCs when 24 years old, compared (p less than 0.001) to women who still used neither an OC nor an IUD. There were no...Continue Reading

References

Apr 1, 1978·American Journal of Obstetrics and Gynecology·O Ylikorkala, M Y Dawood
Sep 1, 1990·Contraception·M NabrinkT Solum
Jan 1, 1974·Current Medical Research and Opinion·B LawE W Hoonakker
Jan 1, 1981·Acta Obstetricia Et Gynecologica Scandinavica·O Lalos, I Joelsson

❮ Previous
Next ❯

Citations

Nov 10, 1998·Contraception·A M Kaunitz
Mar 10, 2001·Fertility and Sterility·A Poindexter
Nov 5, 2002·Fertility and Sterility·Joseph C GamboneUNKNOWN Chronic Pelvic Pain/Endometriosis Working Group
Feb 1, 1996·The Journal of the American Association of Gynecologic Laparoscopists·A J DulebaD L Olive
May 24, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Gregory Zapantis, Nanette Santoro
Aug 2, 2006·Obstetrics and Gynecology·M Yusoff Dawood
Nov 14, 2006·Journal of the Chinese Medical Association : JCMA·Chi-Mou JuangChia-Ming Chang
Feb 1, 1992·American Journal of Obstetrics and Gynecology·J C RobinsonM Ensminger
Dec 6, 2002·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Beth A Collins SharpM Yusoff Dawood
Nov 10, 2011·Contraception·Sanithia L WilliamsE Bimla Schwarz
Jan 18, 2011·Contraception·Jennifer Kerns, Philip Darney
Aug 8, 2009·International Journal of Dermatology·C Stanley ChanTed Rosen
Sep 9, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Intira SriprasertSupanimit Teekachunhatean
Aug 20, 2008·Expert Opinion on Pharmacotherapy·Johannes C HuberClemens B Tempfer
Mar 1, 1995·Journal of Psychosomatic Obstetrics and Gynaecology·J T CondonS Lucy
Aug 25, 2001·American Journal of Obstetrics and Gynecology·A M Kaunitz
Apr 24, 2004·American Journal of Obstetrics and Gynecology·Ronald BurkmanMiriam Zieman
Jul 19, 2016·International Journal of Adolescent Medicine and Health·Fariba GhaderiMohammad Ali Mohseni Bandpei
Nov 2, 2014·Therapeutic Advances in Drug Safety·Jan Brynhildsen
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Chooi L WongMichelle Proctor
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Pietro SantulliCharles Chapron
Aug 5, 2011·Deutsches Ärzteblatt International·Inka Wiegratz, Christian J Thaler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.